A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers.
Andrés NorambuenaHorst WallrabeRui CaoDora Bigler WangAntonia SilvaZdenek SvindrychAmmasi PeriasamySong HuRudolph E TanziDoo Yeon KimGeorge S BloomPublished in: The EMBO journal (2018)
The mechanisms of mitochondrial dysfunction in Alzheimer's disease are incompletely understood. Using two-photon fluorescence lifetime microscopy of the coenzymes, NADH and NADPH, and tracking brain oxygen metabolism with multi-parametric photoacoustic microscopy, we show that activation of lysosomal mechanistic target of rapamycin complex 1 (mTORC1) by insulin or amino acids stimulates mitochondrial activity and regulates mitochondrial DNA synthesis in neurons. Amyloid-β oligomers, which are precursors of amyloid plaques in Alzheimer's disease brain and stimulate mTORC1 protein kinase activity at the plasma membrane but not at lysosomes, block this Nutrient-induced Mitochondrial Activity (NiMA) by a mechanism dependent on tau, which forms neurofibrillary tangles in Alzheimer's disease brain. NiMA was also disrupted in fibroblasts derived from two patients with tuberous sclerosis complex, a genetic disorder that causes dysregulation of lysosomal mTORC1. Thus, lysosomal mTORC1 couples nutrient availability to mitochondrial activity and links mitochondrial dysfunction to Alzheimer's disease by a mechanism dependent on the soluble building blocks of the poorly soluble plaques and tangles.
Keyphrases
- resting state
- mitochondrial dna
- signaling pathway
- cognitive decline
- oxidative stress
- functional connectivity
- copy number
- single molecule
- high resolution
- white matter
- type diabetes
- high throughput
- optical coherence tomography
- epithelial mesenchymal transition
- gene expression
- spinal cord
- high speed
- cell death
- pi k akt
- cerebral ischemia
- endothelial cells
- mass spectrometry
- drug induced
- subarachnoid hemorrhage
- insulin resistance
- cell proliferation
- adipose tissue
- blood brain barrier
- single cell
- high glucose
- induced apoptosis
- photodynamic therapy
- cerebrospinal fluid
- mild cognitive impairment